Table 7 A multiple predictor survival analysis for overall survival
From: A single-center experience: management of patients with thymic epithelial tumors
HR | 95 % Cl for HR | P | |
|---|---|---|---|
Masaoka-Koga stage (I + II vs. III + IV) | 4.876 | 1.145–20.775 | 0.032 |
Complete resection (yes vs. no) | 1.477 | 0.419–5.204 | 0.544 |
Clavien-Dindo (I–IIIa vs. IIIb–IV) | 4.904 | 1.447–16.623 | 0.011 |
Adjuvant chemotherapy (no vs. yes) | 2.803 | 0.530–14.816 | 0.225 |